Mutual Advisors LLC decreased its stake in shares of The Clorox Company (NYSE:CLX – Get Rating) by 10.5% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 1,738 shares of the company's stock after selling 204 shares during the period. Mutual Advisors LLC's holdings in Clorox were worth $244,000 as of its most recent filing with the SEC.

Other hedge funds have also made changes to their positions in the company. SPC Financial Inc. acquired a new position in shares of Clorox during the 3rd quarter valued at about $200,000. Point72 Hong Kong Ltd bought a new position in Clorox in the 3rd quarter worth approximately $51,000. MML Investors Services LLC increased its position in Clorox by 10.1% in the 3rd quarter. MML Investors Services LLC now owns 24,450 shares of the company's stock worth $3,139,000 after buying an additional 2,234 shares during the period. Exchange Traded Concepts LLC bought a new position in Clorox in the 3rd quarter worth approximately $569,000. Finally, DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main increased its position in Clorox by 345.0% in the 2nd quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 63,478 shares of the company's stock worth $8,948,000 after buying an additional 49,213 shares during the period. Institutional investors and hedge funds own 79.12% of the company's stock.

Clorox Price Performance

Shares of CLX stock opened at $157.50 on Monday. The stock's fifty day simple moving average is $150.56 and its 200 day simple moving average is $144.95. The company has a debt-to-equity ratio of 5.04, a current ratio of 0.86 and a quick ratio of 0.47. The firm has a market cap of $19.46 billion, a price-to-earnings ratio of 45.00, a P/E/G ratio of 3.12 and a beta of 0.29. The Clorox Company has a one year low of $120.50 and a one year high of $160.59.

Clorox (NYSE:CLX – Get Rating) last announced its quarterly earnings results on Thursday, February 2nd. The company reported $0.98 EPS for the quarter, beating the consensus estimate of $0.66 by $0.32. The business had revenue of $1.72 billion for the quarter, compared to analyst estimates of $1.66 billion. Clorox had a return on equity of 89.97% and a net margin of 6.16%. Clorox's quarterly revenue was up 1.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.66 EPS. On average, analysts expect that The Clorox Company will post 4.23 earnings per share for the current fiscal year.

Clorox Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 12th. Shareholders of record on Wednesday, April 26th will be paid a $1.18 dividend. This represents a $4.72 dividend on an annualized basis and a yield of 3.00%. The ex-dividend date of this dividend is Tuesday, April 25th. Clorox's dividend payout ratio is currently 134.86%.

Analyst Upgrades and Downgrades

Several research analysts have commented on CLX shares. Barclays dropped their price target on Clorox from $110.00 to $108.00 and set an "underweight" rating on the stock in a research report on Monday, February 6th. Deutsche Bank Aktiengesellschaft dropped their price target on Clorox from $152.00 to $147.00 in a research report on Monday, March 20th. Wells Fargo & Company lifted their price target on Clorox from $125.00 to $135.00 and gave the stock an "underweight" rating in a research report on Tuesday, January 3rd. Raymond James lifted their price target on Clorox from $160.00 to $165.00 and gave the stock an "outperform" rating in a research report on Friday, February 3rd. Finally, Jefferies Financial Group boosted their price objective on Clorox from $140.00 to $145.00 and gave the company a "hold" rating in a research report on Wednesday, February 1st. Seven equities research analysts have rated the stock with a sell rating, six have given a hold rating and one has issued a buy rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Hold" and an average price target of $141.00.

Clorox Company Profile

(Get Rating)

The Clorox Co engages in the manufacture and marketing of consumer and professional products. It operates through the following business segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment consists of cleaning products, professional products and vitamins, minerals and supplements mainly marketed and sold in the United States.

Further Reading

• Get a free copy of the StockNews.com research report on Clorox (CLX)
• MarketBeat Week in Review – 3/20 – 3/24
• Dividend King Genuine Parts Company Upgraded On Profit Guidance
• The Bottom Is In For Accenture
• 11 Best Consumer Discretionary Stocks of 2023
• 5 Best Dividend Capture Stocks

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Get Rating).

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.